31项免疫分析项目脂血可接受阈值的确定
研究依据CLSI C56-A和EP07-ED3:2018指南,用加脂乳液至70 mmol/L的混合样本,在Roche Cobas 6000上评估31项免疫分析项目的脂血干扰。27项分析物即使在高脂血下也无干扰,孕酮、25-OH维生素D、睾酮和雌二醇分别在特定脂血指数阈值下出现负干扰。
要点
- 27项免疫分析项目对脂血干扰稳健,高脂血下仍可报告结果。
- 孕酮在脂血指数217 mg/dL(甘油三酯9.58 mmol/L)时出现负干扰。
- 25-OH维生素D、睾酮、雌二醇的脂血干扰阈值分别为222、478、941 mg/dL。
核心结论
- 多数受评免疫分析项目对脂血干扰稳健,利用上述阈值可在许多情况下报告脂血患者样本的免疫分析结果。
研究设计与样本
- 依据CLSI C56-A和EP07-ED3:2018指南,使用加脂乳液溶液至70 mmol/L的样本池,在Roche Cobas 6000上评估31项免疫分析项目。
主要发现
- 31项分析物中27项即使在最高脂血浓度下也未观察到脂血干扰,脂血指数范围1737至2086 mg/dL,甘油三酯浓度60.34至73.99 mmol/L。
- 孕酮在脂血指数217 mg/dL(甘油三酯9.58 mmol/L)时受负干扰。
- 25-OH维生素D在脂血指数222 mg/dL(甘油三酯10.66 mmol/L)时受负干扰。
- 睾酮在脂血指数478 mg/dL(甘油三酯18.81 mmol/L)时受负干扰。
- 雌二醇在脂血指数941 mg/dL(甘油三酯35.82 mmol/L)时受负干扰。
关键数值与推荐
- 脂血指数阈值:孕酮217 mg/dL,25-OH维生素D 222 mg/dL,睾酮478 mg/dL,雌二醇941 mg/dL。
- 对应甘油三酯浓度阈值:孕酮9.58 mmol/L,25-OH维生素D 10.66 mmol/L,睾酮18.81 mmol/L,雌二醇35.82 mmol/L。
- 27项无干扰分析物的脂血指数范围为1737至2086 mg/dL,甘油三酯浓度范围为60.34至73.99 mmol/L。
临床怎么用
- 实验室可利用上述脂血指数或甘油三酯阈值判断脂血样本的免疫分析结果是否可报告。
- 对孕酮、25-OH维生素D、睾酮和雌二醇,当脂血程度超过对应阈值时应警惕负干扰。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Lipemia is one of common endogenous interferences that can compromises sample quality and potentially influence results of various laboratory methods. Determination of the lipemic index or triglyceride concentrations are used to define the degree of lipemia. This study was aimed to establish lipemic index (LI) and triglyceride thresholds above where significant interference exists for 31 immunoassay analytes measured on Roche Cobas 6000. MATERIALS AND METHODS: The study was carried out following CLSI C56-A and EP07-ED3:2018 guidelines using sample pools spiked with increasing concentrations of lipid emulsion solution, reaching 70 mmol/L. To define the LI and triglyceride thresholds, the bias from concentration in the native sample was calculated at different lipemia degree and compared with allowable error limits based on biological variation or state-of-the-art technology. RESULTS: No lipemia interference was observed for 27 out of 31 analytes even at the highest concentrations of lipid emulsion (LI ranging from 1737 to 2086 mg/dL, triglyceride concentration 60.34-73.99 mmol/L). However, progesterone, 25-OH vitamin D, testosterone, and estradiol were negatively affected by lipemia at 217 mg/dL (9.58 mmol/L), 222 mg/dL (10.66 mmol/L), 478 mg/dL (18.81 mmol/L), and 941 mg/dL (35.82 mmol/L) of the LI (triglyceride concentration), respectively. CONCLUSION: Most immunoassays evaluated in this study were found to be robust to lipemia interference. By using these thresholds, laboratories can report the immunoassay results from analyzing a lipemic patient sample in many cases.
引用
- Ercan Ş, Tat M. Determination of lipemia acceptance thresholds for 31 immunoassay analytes. Clin Chim Acta. 2023. PMID: 37572842. doi:10.1016/j.cca.2023.117508
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。